Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Min-Yeong Woo"'
Publikováno v:
Microorganisms, Vol 8, Iss 9, p 1395 (2020)
T cell immunoglobulin and mucin domain-containing protein-3 (Tim-3) is an immune checkpoint molecule and a target for anti-cancer therapy. In this study, we examined whether gut microbiota manipulation altered the anti-tumour efficacy of Tim-3 blocka
Externí odkaz:
https://doaj.org/article/ab94e69588d34ae3b152465f8c7feaf4
Publikováno v:
2022 25th International Conference on Electrical Machines and Systems (ICEMS).
Publikováno v:
2022 IEEE 20th Biennial Conference on Electromagnetic Field Computation (CEFC).
Publikováno v:
2022 IEEE 20th Biennial Conference on Electromagnetic Field Computation (CEFC).
Publikováno v:
Microorganisms
Volume 8
Issue 9
Microorganisms, Vol 8, Iss 1395, p 1395 (2020)
Volume 8
Issue 9
Microorganisms, Vol 8, Iss 1395, p 1395 (2020)
Background T cell immunoglobulin and mucin domain-containing protein-3 (Tim-3) is an immune checkpoint molecule and a potential target for anti-cancer therapy. Alterations in the tumor-suppressive efficacy of immunotherapy due to gut microbiota distu
Publikováno v:
The Journal of Immunology. 189:5755-5763
Cross-presentation is important for initiating CTL responses against tumors. Delivery of exogenous Ags to the cross-presentation pathway in dendritic cells (DCs), using a number of different carriers, has been attempted to further understand the mech
Publikováno v:
Annals of Dermatology
Background: Behcet disease (BD) is a relapsing inflammatory disease with increased production of inflammatory cyto-kines in peripheral blood mononuclear cells (PBMCs); how-ever, the underlying molecular mechanisms are not well known. Objective: To an
Differentially expressed microRNAs between BD responders and nonresponders to colchicine treatment. (DOCX 11ย�kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92d63026fe99fcfe93916b7f8af2d188
Publikováno v:
British Journal of Dermatology. 167:914-921
Summary Background Colchicine, a first-line drug for the treatment of Behcet disease (BD), inhibits caspase-1 activation and inflammatory cytokine production. However, therapeutic and preventive effects are not observed in some patients with BD. Obje
Publikováno v:
Immune Network
Background T cell immunoglobulin mucin containing molecule (TIM)-3 is expressed in differentiated Th1 cells and is involved in the suppression of the cytokine production by these cells. However, the regulation of the expression of other T cell genes